ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near San Antonio, TX, USA:

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer (KOMODO-1)

kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast ...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: BBI-940

Phase 1

Boundless Bio, Inc.

San Antonio, Texas, United States and 4 other locations

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

San Antonio, Texas, United States and 12 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

San Antonio, Texas, United States of America and 10 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Active, not recruiting
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 34 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Antonio, Texas, United States and 76 other locations

growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to:* Learn how well...

Enrolling
Breast Cancer
Drug: Tucatinib
Drug: Doxil

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 7 other locations

with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...

Enrolling
Breast Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

San Antonio, Texas, United States and 38 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

San Antonio, Texas, United States and 22 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

San Antonio, Texas, United States and 32 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 57 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems